Shares of BNGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Full Answer
Where can I buy shares of bngo?
Shares of BNGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is bngo a good stock to buy for momentum investors?
The financial health and growth prospects of BNGO, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.
What is the bngo stock price prediction for 2026-06-15?
Based on our forecasts, a long-term increase is expected, the "BNGO" stock price prognosis for 2026-06-15 is 44.975 USD. With a 5-year investment, the revenue is expected to be around +489.84%. Your current $100 investment may be up to $589.84 in 2026.
Should you buy BioNano genomics (bngo) stock?
Zacks' proprietary data indicates that Bionano Genomics, Inc. is currently rated as a Zacks Rank 4 and we are expecting a below average return from the BNGO shares relative to the market in the next few months.
See more
Is BNGO a good stock to buy now?
Right now, BNGO stock trades at around the same price as it did before its massive break out to begin 2021. In turn, with this incredible performance last year and its massive potential in genomic analysis, it could be a multi-bagger in the future.
Is BNGO on Robinhood?
Shares of BNGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Is BNGO a US stock?
BNGO Stock Price | Bionano Genomics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch.
Is BNGO a Buy Sell or Hold?
According to the issued ratings of 3 analysts in the last year, the consensus rating for Bionano Genomics stock is Buy based on the current 3 buy ratings for BNGO.
Will BNGO go up?
The 3 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +481.82% increase from the last price of 1.38.
Who owns Bionano genomics?
The Vanguard Group, Inc.The Vanguard Group, Inc.
Does BNGO have FDA approval?
It might be a year before we see $12.... yes, yes I know that BNGO does not need FDA approval to make money...but once FDA approval is established BNGO will be in every hospital in the USA within 2 years.... Every medical insurance company will be wanting everyone to use this technology.
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
How many shares does BNGO have?
Share StatisticsAvg Vol (3 month) 36.91MShares Outstanding 5289.7MImplied Shares Outstanding 6N/AFloat 8284.14M% Held by Insiders 11.92%7 more rows
What is the target price for BNGO?
Stock Price TargetsHigh$12.00Median$8.00Low$6.00Average$8.67Current Price$1.5700
Is BNGO undervalued?
BNGO fair value BNGO ($1.50) is undervalued by... subscribe to Premium to read more.
What is Nio price target?
Stock Price Forecast The 30 analysts offering 12-month price forecasts for NIO Inc have a median target of 30.01, with a high estimate of 81.75 and a low estimate of 21.77. The median estimate represents a +61.01% increase from the last price of 18.64.
Is Bionano Genomics a buy right now?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last twelve months. There are currently 3...
When is Bionano Genomics' next earnings date?
Bionano Genomics is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for Bi...
How were Bionano Genomics' earnings last quarter?
Bionano Genomics, Inc. (NASDAQ:BNGO) issued its quarterly earnings results on Tuesday, March, 1st. The company reported ($0.08) EPS for the quarter...
What guidance has Bionano Genomics issued on next quarter's earnings?
Bionano Genomics issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided EPS guidance of for the period. The c...
What price target have analysts set for BNGO?
3 analysts have issued 12-month price targets for Bionano Genomics' stock. Their forecasts range from $7.00 to $14.00. On average, they expect Bion...
Who are Bionano Genomics' key executives?
Bionano Genomics' management team includes the following people: Dr. Robert Erik Holmlin M.B.A. , Ph.D., Pres, CEO, Sec. & Director (Age 54, Pay...
What is R. Erik Holmlin's approval rating as Bionano Genomics' CEO?
10 employees have rated Bionano Genomics CEO R. Erik Holmlin on Glassdoor.com . R. Erik Holmlin has an approval rating of 73% among Bionano Genomi...
Who are some of Bionano Genomics' key competitors?
Some companies that are related to Bionano Genomics include Olink Holding AB (publ) (OLK) , Pacific Biosciences of California (PACB) , Cytek Bio...
What other stocks do shareholders of Bionano Genomics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Bionano Genomics investors own include Matinas BioPharma (...
What is BNGO in genomics?
BNGO is a leader in the digital cytogenetics niche. Its genome-imaging system, Saphyr, is arguably the most advanced hardware of its class today. Meanwhile, the global genomics market is expected to increase from $20 billion today to $80 billion by 2027.
What is market order?
Market order: A simple order that instructs your broker to purchase a selected number of shares on the market. This type of order does not specify a price, just a number of shares. Limit order: This type of order instructs your broker to purchase a selected number of shares only at a certain price (or better).
What is Benzinga's weighted scale?
For brokerage reviews, Benzinga created a weighted scale based on the following criteria: usability, services offered, customer service, education, research, mobile app, account minimums and fees. We aim to provide the most up-to-date, impactful and trustworthy reviews. For an in-depth look at our process, read the full methodology process.
Does Benzinga recommend trading?
Benzinga does not recommend trading or investing in low-priced stocks if you haven’t had at least a couple of years of experience in the stock market. For a full statement of our disclaimers, please click here. Get 4 FREE stocks valued up to $3700! claim now. Get 4 FREE stocks valued up to $3700!
Signals & Forecast
There are mixed signals in the stock today. The BioNano Genomics Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Support, Risk & Stop-loss
BioNano Genomics Inc. finds support from accumulated volume at $1.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is BioNano Genomics Inc. stock A Buy?
BioNano Genomics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Insiders are very positive buying more shares than they are selling in BioNano Genomics Inc
In the last 100 trades there were 23.1 million shares bought and 8.97 million shares sold. The last trade was done 6 days ago by Holmlin R. Erik who bough 1.4 million shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
About Bionano Genomics
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.
Bionano Genomics (NASDAQ:BNGO) Frequently Asked Questions
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bionano Genomics in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Bionano Genomics stock. View analyst ratings for Bionano Genomics or view top-rated stocks.
Bionano Genomics
Some stock charts might currently not be supported. To try again, please refresh this page.
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space.
Rating
What analysts recommend for this stock, on a scale from 1 (buy) to 5 (sell).
Key Drivers – BNGO Stock Price Forecast 2021 and 2022
The best shares to buy now often are those in the growth phase of their lifecycle yet have strong fundamentals to back up any potential investment. Bionano Genomics (BNGO) certainly fit this bill and aim to expand their business over the coming year. Let’s discuss what Bionano Genomics do and the outlook for the BNGO stock price.
BNGO Stock Price Forecast – Short Term Outlook
The best companies to invest in over the short term tend to have good technical and fundamental elements. In Bionano Genomics’ case, the technicals aren’t ideal at present, as you can see from the previous section. Price is still trickling down with very low momentum, which signifies that some impetus is needed to turn things around.
BNGO Stock Price Forecast – Long-Term Outlook
Now let’s turn our attention to the long term. Small-cap stocks are an appealing prospect for investors with a long-term investment horizon, as they offer the chance at generating incredible returns. However, there are so many to choose from, so it’s essential to do your due diligence and come to a rational valuation of the company’s stock.
How to Buy BNGO Stock?
The final element of this BNGO stock forecast focuses on the investment process. If you wish to buy stocks, you’ll need to create an account with a licensed and regulated broker to facilitate your trade. These brokers automatically pair buyers and sellers together, offering a seamless investing experience for all parties.
BNGO Stock Price Forecast – Final Word
To summarise, this BNGO stock forecast has explored what Bionano Genomics does and the outlook for the company’s stock. We’ve also highlighted where you can buy BNGO today – with no commissions.
FAQs
Bionano Genomics (BNGO) is a pharmaceuticals company that offers genome mapping tools for use in a research setting. The company’s Saphyr system aims to streamline the process, meaning diseases can be treated sooner and more efficiently.
About Connor Brooke PRO INVESTOR
Connor is a Scottish financial expert, specialising in wealth management and equity investing. Based in Glasgow, Connor writes full-time for a wide selection of financial websites, whilst also providing startup consulting to small businesses.
Does Zackstrade endorse or recommend investment strategies?
The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
Is a B better than a C?
An A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. Value Score A. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B.
